Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberta Romano

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Genes|March 28, 2024
Understanding the Variability of 22q11.2 Deletion Syndrome: The Role of Epigenetic FactorsFrancesca Cillo, Emma Coppola, Federico Habetswallner, et al.
Frontiers in Immunology|April 18, 2024
Case report: EBV-related eye orbits and sinuses lymphohistiocytic infiltration responsive to rituximab in a patient with X lymphoproliferative syndrome type 1Giuliana Giardino, Vittoria Lanni, Massimo Mascolo, et al.
Immunology|August 31, 2022
Epigenetics: An opportunity to shape innate and adaptive immune responsesAntonietta Liotti, Anne Lise Ferrara, Stefania Loffredo, et al.
Clinical Immunology (Orlando, Fla.)|March 26, 2023
Immune tolerance breakdown in inborn errors of immunity: Paving the way to novel therapeutic approachesGiuliana Giardino, Roberta Romano, Vassilios Lougaris, et al.
Frontiers in Immunology|February 7, 2025
Characterization of a <i>WAS</i> splice-site variant in a patient with Wiskott-Aldrich syndromeElisabetta Toriello, Rosa Maritato, Antonio De Rosa, et al.
Cells|April 25, 2020
Charcot-Marie-Tooth Type 2B: A New Phenotype Associated with a Novel <i>RAB7A</i> Mutation and Inhibited EGFR DegradationPaola Saveri, Maria De Luca, Veronica Nisi, et al.
The New England Journal of Medicine|August 16, 2023
Gene Therapy in Patients with the Crigler-Najjar SyndromeLorenzo D'Antiga, Ulrich Beuers, Giuseppe Ronzitti, et al.
Med (New York, N.Y.)|November 15, 2024
Multi-year enzyme expression in patients with mucopolysaccharidosis type VI after liver-directed gene therapyAlessandro Rossi, Roberta Romano, Simona Fecarotta, et al.
Cellular and Molecular Life Sciences : CMLS|March 31, 2023
Functional effects of disease-associated variants reveal that the S1-M1 linker of the NMDA receptor critically controls channel openingLingling Xie, Miranda J McDaniel, Riley E Perszyk, et al.
Journal of Clinical Immunology|November 3, 2023
Correction to: Antibody Deficiency in Patients with Biallelic KARS1 MutationsFrancesco Saettini, Fabiola Guerra, Grazia Fazio, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Genes|March 28, 2024
Understanding the Variability of 22q11.2 Deletion Syndrome: The Role of Epigenetic FactorsFrancesca Cillo, Emma Coppola, Federico Habetswallner, et al.
Frontiers in Immunology|April 18, 2024
Case report: EBV-related eye orbits and sinuses lymphohistiocytic infiltration responsive to rituximab in a patient with X lymphoproliferative syndrome type 1Giuliana Giardino, Vittoria Lanni, Massimo Mascolo, et al.
Immunology|August 31, 2022
Epigenetics: An opportunity to shape innate and adaptive immune responsesAntonietta Liotti, Anne Lise Ferrara, Stefania Loffredo, et al.
Clinical Immunology (Orlando, Fla.)|March 26, 2023
Immune tolerance breakdown in inborn errors of immunity: Paving the way to novel therapeutic approachesGiuliana Giardino, Roberta Romano, Vassilios Lougaris, et al.
Frontiers in Immunology|February 7, 2025
Characterization of a <i>WAS</i> splice-site variant in a patient with Wiskott-Aldrich syndromeElisabetta Toriello, Rosa Maritato, Antonio De Rosa, et al.
Cells|April 25, 2020
Charcot-Marie-Tooth Type 2B: A New Phenotype Associated with a Novel <i>RAB7A</i> Mutation and Inhibited EGFR DegradationPaola Saveri, Maria De Luca, Veronica Nisi, et al.
The New England Journal of Medicine|August 16, 2023
Gene Therapy in Patients with the Crigler-Najjar SyndromeLorenzo D'Antiga, Ulrich Beuers, Giuseppe Ronzitti, et al.
Med (New York, N.Y.)|November 15, 2024
Multi-year enzyme expression in patients with mucopolysaccharidosis type VI after liver-directed gene therapyAlessandro Rossi, Roberta Romano, Simona Fecarotta, et al.
Cellular and Molecular Life Sciences : CMLS|March 31, 2023
Functional effects of disease-associated variants reveal that the S1-M1 linker of the NMDA receptor critically controls channel openingLingling Xie, Miranda J McDaniel, Riley E Perszyk, et al.
Journal of Clinical Immunology|November 3, 2023
Correction to: Antibody Deficiency in Patients with Biallelic KARS1 MutationsFrancesco Saettini, Fabiola Guerra, Grazia Fazio, et al.
Pageof 8